Gregory L. Verdine, Ph.D., Harvard College Professor and Erving Professor of Chemistry, Department of Cellular and Molecular Biology, Harvard University, and Founder and Co-Chairman, Scientific Advisory Board, Aileron Therapeutics

Previous articleFDA Gives Abbott a Thumbs-Up for Automated HBV Monitoring Test
Next articleVeritas to Market Epistem’s Epithelial Stem Cell-Based Research Services in Japan